S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ACHL Achilles Therapeutics PLC

0.81

0.03 (3.85%)

May 03 2024 - Closed

Delayed by 15 minutes

Achilles Therapeutics EPS beats by $0.15

To read the full story on Seeking Alpha, click here.

Achilles Therapeutics (NASDAQ:ACHL)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Achilles Therapeutics Charts.

Achilles Therapeutics (NASDAQ:ACHL)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Achilles Therapeutics Charts.

Achilles Therapeutics PLC News

Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
Thursday 4 April 2024 (1 month ago) • GlobeNewswire Inc.

Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning
Thursday 4 April 2024 (1 month ago) • GlobeNewswire Inc.

Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference
Monday 5 February 2024 (3 months ago) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Thursday 1 February 2024 (3 months ago) • Edgar (US Regulatory)

Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction
Monday 18 December 2023 (5 months ago) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 13 November 2023 (6 months ago) • Edgar (US Regulatory)

Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights
Monday 13 November 2023 (6 months ago) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Wednesday 1 November 2023 (6 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 22 September 2023 (7 months ago) • Edgar (US Regulatory)

Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
Friday 22 September 2023 (7 months ago) • GlobeNewswire Inc.

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
Wednesday 20 September 2023 (7 months ago) • InvestorsHub NewsWire

Form 144 - Report of proposed sale of securities
Thursday 17 August 2023 (9 months ago) • Edgar (US Regulatory)

More Achilles Therapeutics PLC News Articles

Alternet Systems (PK)

Marketing Worldwide (PK)

Bell Buckle (PK)

Yuenglings Ice Cream (PK)

Ubiquitech Software (PK)

Umbra Applied Technologies (PK)

Moon Equity (PK)

Auto Parts 4Less (PK)

AMC Entertainment

Brookmount Explorations (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions